Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection. 2018

Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
Department of Thoracic and Cardiovascular Surgery, Nara Medical University School of Medicine, Kashihara, Japan myasukawa@naramed-u.ac.jp.

OBJECTIVE Although the 2015 World Health Organization Classification reported that histological grading may be helpful in lung cancer management, a widely accepted histological grading system with clearly defined criteria and demonstrable clinical significance has not been developed. We investigated the prognoses of patients with resected non-small cell lung cancer (NSCLC) to identify prognostic factors, especially histological grade. METHODS The medical records of 531 patients between 2010 and 2015 were retrospectively reviewed. Overall survival (OS) curve was plotted using the Kaplan-Meier method. Cox regression analyses were used to evaluate the hazard ratio (HR) with endpoint of OS. RESULTS The 5-year OS rate in groups with histological grade 1, grade 2, and grade 3+4 groups was 95.8%, 85.7%, and 72.1%, respectively (p<0.001). Multivariate analysis identified histological grade and vascular invasion as independent predictors of OS [histological grade: HR=1.533, p=0.002]. CONCLUSIONS Histological grade was an independent prognostic factor of patients resected for all stages of NSCLC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D053208 Kaplan-Meier Estimate A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995) Kaplan-Meier Survival Curve,Kaplan-Meier Analysis,Kaplan-Meier Survival Curves,Kaplan-Meier Test,Product-Limit Method,Analysis, Kaplan-Meier,Curve, Kaplan-Meier Survival,Curves, Kaplan-Meier Survival,Estimate, Kaplan-Meier,Kaplan Meier Analysis,Kaplan Meier Survival Curve,Kaplan Meier Survival Curves,Kaplan Meier Test,Method, Product-Limit,Methods, Product-Limit,Product Limit Method,Product-Limit Methods,Survival Curve, Kaplan-Meier,Survival Curves, Kaplan-Meier,Test, Kaplan-Meier

Related Publications

Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
April 2014, Oncology letters,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
December 2013, The Korean journal of thoracic and cardiovascular surgery,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
April 2002, The Annals of thoracic surgery,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
April 2008, Deutsches Arzteblatt international,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
June 2012, The Annals of thoracic surgery,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
December 1992, Mayo Clinic proceedings,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
November 2006, Deutsche medizinische Wochenschrift (1946),
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
October 2013, The Journal of thoracic and cardiovascular surgery,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
March 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Motoaki Yasukawa, and Noriyoshi Sawabata, and Takeshi Kawaguchi, and Norikazu Kawai, and Tokiko Nakai, and Chiho Ohbayashi, and Shigeki Taniguchi
November 2007, Ai zheng = Aizheng = Chinese journal of cancer,
Copied contents to your clipboard!